Question:
That’s very white of you, Keith. I’d say magnaminous, but I’d offered to send you .pdf files from several psychiatry journals over the past two years or so and you never expressed any interest. Looks like Julez is in a "sharing" mood for a change. While you’re at it, why don’t you have dysphoric, retentive/explosive Agileflower send you what I sent her — the special Sept. 15 2000 _Biological Psychiatry_ issue on bipolar disorder. I won’t post waste five minutes on feeding the dregzz *anything* from my extensive collection. They’re unworthy – period. Viscount of ASDManic ~~ Let them eat cake.. – Hide quoted text — Show quoted text – > The Journal of Clinical Psychiatry….catch up on your reading…your > doctor doesn’t have the time to keep up! > Alright, request your issues by the month and I’ll email the .pdf file > to you. If you don’t want to post your email then send your request to > Consult the table of contents below…I have July through November > available… > Keith sez knowledge should be free and thanks to those who made it so. > Volume 61 November 2000 Number 11 > Brainstorms > 813 The New Cholinesterase Inhibitors for Alzheimer’s Disease, Part 2: > Illustrating Their Mechanisms of Action. Stephen M. Stahl > Original Articles > 815 Adverse Neuropsychiatric Reactions to Herbal and Over-the-Counter > "Antidepressants." Ronald Pies > 821 Treatment of Dysthymia With Sertraline: A Double-Blind, > Placebo-Controlled Trial in Dysthymic Patients Without Major > Depression. Arun V. Ravindran, Julien D. Guelfi, Roger M. Lane, and > Giovanni B. Cassano > 828 Paroxetine Levels in Postpartum Depressed Women, Breast Milk, and > Infant Serum. Shaila Misri, John Kim, K. Wayne Riggs, and Xanthoula > Kostaras > 833 Strategies for Switching From Conventional Antipsychotic Drugs or > Risperidone to Olanzapine. Bruce J. Kinon, Bruce R. Basson, Julie A. > Gilmore, Sandra Malcolm, and Virginia L. Stauffer > 841 A Double-Blind, Placebo-Controlled, Prophylaxis Study of > Lamotrigine in Rapid-Cycling Bipolar Disorder. Joseph R. Calabrese, > Trisha Suppes, Charles L. Bowden, Gary S. Sachs, Alan C. Swann, Susan > L. McElroy, Vivek Kusumakar, John A. Ascher, Nancy L. Earl, Paul L. > Greene, and Eileen T. Monaghan, for the Lamictal 614 Study Group > 851 The Efficacy and Safety of a New Enteric-Coated Formulation of > Fluoxetine Given Once Weekly During the Continuation Treatment of > Major Depressive Disorder. Mark E. Schmidt, Maurizio Fava, James M. > Robinson, and Rajinder Judge > 858 Bupropion SR Reduces Periodic Limb Movements Associated With > Arousals From Sleep in Depressed Patients With Periodic Limb Movement > Disorder. Eric A. Nofzinger, Amy Fasiczka, Susan Berman, and Michael > E. Thase > 863 Fluoxetine Versus Sertraline and Paroxetine in Major Depressive > Disorder: Changes in Weight With Long-Term Treatment. Maurizio Fava, > Rajinder Judge, Sharon L. Hoog, Mary E. Nilsson, and Stephanie C. Koke > 868 Schizophrenia-Associated Idiopathic Unconjugated > Hyperbilirubinemia (Gilbert’s Syndrome). Tsuyoshi Miyaoka, Haruo Seno, > Motoi Itoga, Masaaki Iijima, Takuji Inagaki,and Jun Horiguchi > CME Article 879 > 880 Differences in Quality of Life Domains and Psychopathologic and > Psychosocial Factors in Psychiatric Patients. Michael Ritsner, Ilan > Modai, Jean Endicott, Olga Rivkin, Yakov Nechamkin, Peretz Barak, > Vladimir Goldin, and Alexander Ponizovsky > Letters to the Editor > 872 Reboxetine Treatment of Depression in Parkinson’s Disease. > Matthias R. Lemke > 872 Olanzapine-Induced Neutropenia in Patients With History of > Clozapine Treatment: Two Case Reports From a State Psychiatric > Institution. Christian J. Teter, John J. Early, and Richard J. > Frachtling > 873 Venlafaxine Versus Sertraline for Major Depressive Disorder. > Thomas N. Wise and Michael J. Sheridan > 874 Adverse Events of Fluoxetine: Postmarketing Compared With > Premarketing Clinical Trials. Mahmoud N. Musa and James M. Staneluis > 874 Diagnosing Melancholia. Iwona Chelminski, Mark Zimmerman, and Jill > I. Mattia > Volume 61 October 2000 Number 10 > Brainstorms > 710 The New Cholinesterase Inhibitors for Alzheimer’s Disease, Part 1: > Their Similarities Are Different. Stephen M. Stahl > Original Articles > 712 How Fast Are Antidepressants? Alan J. Gelenberg and Chelsea L. > Chesen > 722 Efficacy, Adverse Events, and Treatment Discontinuations in > Fluoxetine Clinical Studies of Major Depression: A Meta-Analysis of > the 20-mg/day Dose.Charles M. Beasley, Jr., Mary E. Nilsson, Stephanie > C. Koke, and Jill S. Gonzales > 729 Prodromal Symptoms of Relapse in a Sample of Egyptian > Schizophrenic Patients. Ahmed Okasha, Zeinab Bishry, Mohamed Rifaat El > Fiki, Aida Seif El Dawla, and Amany Haroun El Rasheed > 737 Restlessness of Respiration as a Manifestation of Akathisia: Five > Case Reports of Respiratory Akathisia. Shigehiro Hirose > 742 Elevated Levels of Insulin, Leptin, and Blood Lipids in > Olanzapine-Treated Patients With Schizophrenia or Related Psychoses. > Kristina I. Melkersson, Anna-Lena Hulting, and Kerstin E. Brismar > 750 Treatment of Depression With Methylphenidate in Patients Difficult > to Wean From Mechanical Ventilation in the Intensive Care Unit. > Hans-Bernd Rothenhausler, Sigrid Ehrentraut, Georges von Degenfeld, > Michael Weis, Monika Tichy, Erich Kilger, Christian Stoll, Gustav > Schelling, and Hans-Peter Kapfhammer > 756 Genetic Studies of Panic Disorder: A Review. Odile A. van den > Heuvel, Ben J. M. van de Wetering, Dick J. Veltman, and David L. Pauls > 767 An Algorithm for the Treatment of Schizophrenia in the > Correctional Setting: The Forensic Algorithm Project. Charles A. > Buscema, Qamar A. Abbasi, David J. Barry, and Timothy H. Lauve > Academic Highlights > 791 Alzheimer’s Disease: Translating Neurochemical Insights Into > Clinical Benefits. > CME Article 803 > 804 Diagnosing Bipolar Disorder and the Effect of Antidepressants: A > Naturalistic Study. S. Nassir Ghaemi, Erica E. Boiman, and Frederick > K. Goodwin > Letters to the Editor > 784 EMDR for Treatment of PTSD. -Gary Peterson****-Nancy J. Smyth, > Ricky Greenwald, Ad de Jongh, and Christopher Lee > Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances > 785 Further Discussion of EMDR for Treatment of PTSD. Charles R. > Figley, Andrew M. Leeds, Sandra A. TinkerWilson, and Bessel A. van der > Kolk > Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances > 786 Omission of Bupropion as a Recommended Treatment for PTSD. Ralph > M. Reeves > Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances > 787 Psychodynamic Psychotherapy for PTSD. -Jose A. Saporta****-Eric M. > Plakun and Edward R. Shapiro > Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances > Book Reviews 789 > Volume 61 September 2000 Number 9 > Brainstorms > 628 Paying Attention to Your Acetylcholine, Part 2: The Function of > Nicotinic Receptors. Stephen M. Stahl > Original Articles > 630 The Implications of Genetic Studies of Major Mood Disorders for > Clinical Practice. Anne Duffy, Paul Grof, Carrie Robertson, and Martin > Alda > 638 A Naturalistic Comparison of Clozapine, Risperidone, and > Olanzapine in the Treatment of Bipolar Disorder. Constance Guille, > Gary S. Sachs, and S. Nassir Ghaemi > 643 A Randomized, Double-Blind, Placebo-Controlled Trial of > Moclobemide in Patients With Chronic Fatigue Syndrome. Ian B. Hickie, > Andrew J. Wilson, J. Murray Wright, Barbara K. Bennett, Denis > Wakefield, and Andrew R. Lloyd > 649 Possible Induction of Mania and Hypomania by Olanzapine or > Risperidone: A Critical Review of Reported Cases. Jean-Michel Aubry, > Andor E. Simon, and Gilles Bertschy > 656 Mirtazapine Compared With Paroxetine in Major Depression. Otto > Benkert, Armin Szegedi, and Ralf Kohnen > 664 Psychostimulant Augmentation During Treatment With Selective > Serotonin Reuptake Inhibitors in Men With Paraphilias and > Paraphilia-Related Disorders: A Case Series. Martin P. Kafka and John > Hennen > 671 Clinical and Psychopharmacologic Factors Influencing Family Burden > in Refractory Schizophrenia. Robert Rosenheck, Joyce Cramer, George > Jurgis, Deborah Perlick, Weichun Xu, Jonathan Thomas, William > Henderson, and Dennis Charney, for the Department of Veterans Affairs > Cooperative Study Group on Clozapine in Refractory Schizophrenia > Academic Highlights > 686 Novel Antidepressant Strategies to Optimize Outcome. > CME Article 697 > 698 Psychiatric Care of Patients With Depression and Comorbid > Substance Use Disorders. Ivan D. Montoya, Dace Svikis, Steven C. > Marcus, Ana Suarez, Terri Tanielian, and Harold Alan Pincus > Letters to the Editor > 677 Association Between Premenstrual Syndrome and Depression. Claudio > N. Soares and Lee S. Cohen > Reply by Catherine A. Roca, Peter J. Schmidt, and David R. Rubinow > 678 Is Antipsychotic Drug-Induced Weight Gain Associated With a > Favorable Clinical Response? J. Steven Lamberti > Reply by Rohan Ganguli > 678 Polypharmacy of 2 Atypical Antipsychotics. Edward Rhoads > Reply by Stephen M. Stahl > 680 Clarification of Anticholinergic Effects of Quetiapine. Jeffrey M. > Goldstein and Martin Brecher > 680 Side Effect Profile of Enteric-Coated Divalproex Sodium Versus > Valproic Acid. Joseph Levine, K. N. Roy Chengappa, and Haranath > Parepally > 681 Correction. Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno > F, Zentner L, and Delgado P. Mirtazapine substitution in SSRI-induced > sexual dysfunction (J Clin Psychiatry 2000;61:356-360) > Book Reviews 682 > Volume 61 August 2000 Number 8 > Brainstorms > 547 Paying Attention to Your Acetylcholine, Part 1: Structural > Organization of Nicotinic Receptors. Stephen M. Stahl > Original
… read more »
Response:
The Journal of Clinical Psychiatry….catch up on your reading…your doctor doesn’t have the time to keep up! Alright, request your issues by the month and I’ll email the .pdf file to you. If you don’t want to post your email then send your request to Consult the table of contents below…I have July through November available… Keith sez knowledge should be free and thanks to those who made it so. Volume 61 November 2000 Number 11 Brainstorms 813 The New Cholinesterase Inhibitors for Alzheimer’s Disease, Part 2: Illustrating Their Mechanisms of Action. Stephen M. Stahl Original Articles 815 Adverse Neuropsychiatric Reactions to Herbal and Over-the-Counter "Antidepressants." Ronald Pies 821 Treatment of Dysthymia With Sertraline: A Double-Blind, Placebo-Controlled Trial in Dysthymic Patients Without Major Depression. Arun V. Ravindran, Julien D. Guelfi, Roger M. Lane, and Giovanni B. Cassano 828 Paroxetine Levels in Postpartum Depressed Women, Breast Milk, and Infant Serum. Shaila Misri, John Kim, K. Wayne Riggs, and Xanthoula Kostaras 833 Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine. Bruce J. Kinon, Bruce R. Basson, Julie A. Gilmore, Sandra Malcolm, and Virginia L. Stauffer 841 A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder. Joseph R. Calabrese, Trisha Suppes, Charles L. Bowden, Gary S. Sachs, Alan C. Swann, Susan L. McElroy, Vivek Kusumakar, John A. Ascher, Nancy L. Earl, Paul L. Greene, and Eileen T. Monaghan, for the Lamictal 614 Study Group 851 The Efficacy and Safety of a New Enteric-Coated Formulation of Fluoxetine Given Once Weekly During the Continuation Treatment of Major Depressive Disorder. Mark E. Schmidt, Maurizio Fava, James M. Robinson, and Rajinder Judge 858 Bupropion SR Reduces Periodic Limb Movements Associated With Arousals From Sleep in Depressed Patients With Periodic Limb Movement Disorder. Eric A. Nofzinger, Amy Fasiczka, Susan Berman, and Michael E. Thase 863 Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder: Changes in Weight With Long-Term Treatment. Maurizio Fava, Rajinder Judge, Sharon L. Hoog, Mary E. Nilsson, and Stephanie C. Koke 868 Schizophrenia-Associated Idiopathic Unconjugated Hyperbilirubinemia (Gilbert’s Syndrome). Tsuyoshi Miyaoka, Haruo Seno, Motoi Itoga, Masaaki Iijima, Takuji Inagaki,and Jun Horiguchi CME Article 879 880 Differences in Quality of Life Domains and Psychopathologic and Psychosocial Factors in Psychiatric Patients. Michael Ritsner, Ilan Modai, Jean Endicott, Olga Rivkin, Yakov Nechamkin, Peretz Barak, Vladimir Goldin, and Alexander Ponizovsky Letters to the Editor 872 Reboxetine Treatment of Depression in Parkinson’s Disease. Matthias R. Lemke 872 Olanzapine-Induced Neutropenia in Patients With History of Clozapine Treatment: Two Case Reports From a State Psychiatric Institution. Christian J. Teter, John J. Early, and Richard J. Frachtling 873 Venlafaxine Versus Sertraline for Major Depressive Disorder. Thomas N. Wise and Michael J. Sheridan 874 Adverse Events of Fluoxetine: Postmarketing Compared With Premarketing Clinical Trials. Mahmoud N. Musa and James M. Staneluis 874 Diagnosing Melancholia. Iwona Chelminski, Mark Zimmerman, and Jill I. Mattia Volume 61 October 2000 Number 10 Brainstorms 710 The New Cholinesterase Inhibitors for Alzheimer’s Disease, Part 1: Their Similarities Are Different. Stephen M. Stahl Original Articles 712 How Fast Are Antidepressants? Alan J. Gelenberg and Chelsea L. Chesen 722 Efficacy, Adverse Events, and Treatment Discontinuations in Fluoxetine Clinical Studies of Major Depression: A Meta-Analysis of the 20-mg/day Dose.Charles M. Beasley, Jr., Mary E. Nilsson, Stephanie C. Koke, and Jill S. Gonzales 729 Prodromal Symptoms of Relapse in a Sample of Egyptian Schizophrenic Patients. Ahmed Okasha, Zeinab Bishry, Mohamed Rifaat El Fiki, Aida Seif El Dawla, and Amany Haroun El Rasheed 737 Restlessness of Respiration as a Manifestation of Akathisia: Five Case Reports of Respiratory Akathisia. Shigehiro Hirose 742 Elevated Levels of Insulin, Leptin, and Blood Lipids in Olanzapine-Treated Patients With Schizophrenia or Related Psychoses. Kristina I. Melkersson, Anna-Lena Hulting, and Kerstin E. Brismar 750 Treatment of Depression With Methylphenidate in Patients Difficult to Wean From Mechanical Ventilation in the Intensive Care Unit. Hans-Bernd Rothenhausler, Sigrid Ehrentraut, Georges von Degenfeld, Michael Weis, Monika Tichy, Erich Kilger, Christian Stoll, Gustav Schelling, and Hans-Peter Kapfhammer 756 Genetic Studies of Panic Disorder: A Review. Odile A. van den Heuvel, Ben J. M. van de Wetering, Dick J. Veltman, and David L. Pauls 767 An Algorithm for the Treatment of Schizophrenia in the Correctional Setting: The Forensic Algorithm Project. Charles A. Buscema, Qamar A. Abbasi, David J. Barry, and Timothy H. Lauve Academic Highlights 791 Alzheimer’s Disease: Translating Neurochemical Insights Into Clinical Benefits. CME Article 803 804 Diagnosing Bipolar Disorder and the Effect of Antidepressants: A Naturalistic Study. S. Nassir Ghaemi, Erica E. Boiman, and Frederick K. Goodwin Letters to the Editor 784 EMDR for Treatment of PTSD. -Gary Peterson****-Nancy J. Smyth, Ricky Greenwald, Ad de Jongh, and Christopher Lee Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances 785 Further Discussion of EMDR for Treatment of PTSD. Charles R. Figley, Andrew M. Leeds, Sandra A. TinkerWilson, and Bessel A. van der Kolk Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances 786 Omission of Bupropion as a Recommended Treatment for PTSD. Ralph M. Reeves Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances 787 Psychodynamic Psychotherapy for PTSD. -Jose A. Saporta****-Eric M. Plakun and Edward R. Shapiro Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances Book Reviews 789 Volume 61 September 2000 Number 9 Brainstorms 628 Paying Attention to Your Acetylcholine, Part 2: The Function of Nicotinic Receptors. Stephen M. Stahl Original Articles 630 The Implications of Genetic Studies of Major Mood Disorders for Clinical Practice. Anne Duffy, Paul Grof, Carrie Robertson, and Martin Alda 638 A Naturalistic Comparison of Clozapine, Risperidone, and Olanzapine in the Treatment of Bipolar Disorder. Constance Guille, Gary S. Sachs, and S. Nassir Ghaemi 643 A Randomized, Double-Blind, Placebo-Controlled Trial of Moclobemide in Patients With Chronic Fatigue Syndrome. Ian B. Hickie, Andrew J. Wilson, J. Murray Wright, Barbara K. Bennett, Denis Wakefield, and Andrew R. Lloyd 649 Possible Induction of Mania and Hypomania by Olanzapine or Risperidone: A Critical Review of Reported Cases. Jean-Michel Aubry, Andor E. Simon, and Gilles Bertschy 656 Mirtazapine Compared With Paroxetine in Major Depression. Otto Benkert, Armin Szegedi, and Ralf Kohnen 664 Psychostimulant Augmentation During Treatment With Selective Serotonin Reuptake Inhibitors in Men With Paraphilias and Paraphilia-Related Disorders: A Case Series. Martin P. Kafka and John Hennen 671 Clinical and Psychopharmacologic Factors Influencing Family Burden in Refractory Schizophrenia. Robert Rosenheck, Joyce Cramer, George Jurgis, Deborah Perlick, Weichun Xu, Jonathan Thomas, William Henderson, and Dennis Charney, for the Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia Academic Highlights 686 Novel Antidepressant Strategies to Optimize Outcome. CME Article 697 698 Psychiatric Care of Patients With Depression and Comorbid Substance Use Disorders. Ivan D. Montoya, Dace Svikis, Steven C. Marcus, Ana Suarez, Terri Tanielian, and Harold Alan Pincus Letters to the Editor 677 Association Between Premenstrual Syndrome and Depression. Claudio N. Soares and Lee S. Cohen Reply by Catherine A. Roca, Peter J. Schmidt, and David R. Rubinow 678 Is Antipsychotic Drug-Induced Weight Gain Associated With a Favorable Clinical Response? J. Steven Lamberti Reply by Rohan Ganguli 678 Polypharmacy of 2 Atypical Antipsychotics. Edward Rhoads Reply by Stephen M. Stahl 680 Clarification of Anticholinergic Effects of Quetiapine. Jeffrey M. Goldstein and Martin Brecher 680 Side Effect Profile of Enteric-Coated Divalproex Sodium Versus Valproic Acid. Joseph Levine, K. N. Roy Chengappa, and Haranath Parepally 681 Correction. Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, and Delgado P. Mirtazapine substitution in SSRI-induced sexual dysfunction (J Clin Psychiatry 2000;61:356-360) Book Reviews 682 Volume 61 August 2000 Number 8 Brainstorms 547 Paying Attention to Your Acetylcholine, Part 1: Structural Organization of Nicotinic Receptors. Stephen M. Stahl Original Articles 549 Clinical Factors Associated With Treatment Noncompliance in Euthymic Bipolar Patients. Francesc Colom, Eduard Vieta, Anabel Martinez-Aran, Maria Reinares, Antonio Benabarre, and Cristobal Gasto 556 Is Melatonin Treatment Effective for Tardive Dyskinesia? Eyal Shamir, Yoram Barak, Igor Plopsky, Nava Zisapel, Avner Elizur, and Abraham Weizman 559 A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients. Paul A. Newhouse, K. Ranga Rama Krishnan, P. Murali Doraiswamy, Ellen M. Richter, Evan D. Batzar, and Cathryn M. Clary 569 Pisa Syndrome (Pleurothotonus): Report of a Multicenter Drug Safety Surveillance Project. Susanne Stubner, Frank Padberg, Renate Grohmann, Harald Hampel, Matthias Hollweg, Hanns Hippius, Hans-Jurgen Moller, and Eckart Ruther 575 An Open-Label Trial of St. John’s Wort (Hypericum perforatum) in Obsessive-Compulsive Disorder. Leslie vH. Taylor and Kenneth A. Kobak 579 Predictors of Response to Sertraline Treatment of Severe Premenstrual Syndromes. Ellen W. Freeman, Steven J. Sondheimer, … read more »
Response: